|
Re: ABCA1 overexpression worsens colorectal cancer prognosis and this can be ameliorated by apabetalone
|
4
|
Resverlogix Corp.
|
Aug 24, 2018 02:53PM
|
|
Re: Accelerated approval
|
4
|
Zenith Epigenetics
|
Oct 17, 2019 12:43PM
|
|
Re: Accelerated approval
|
3
|
Zenith Epigenetics
|
Oct 17, 2019 12:48PM
|
|
Re: Accelerated approval
|
3
|
Zenith Epigenetics
|
Oct 21, 2019 02:27PM
|
|
Re: Added a few more to the pile...
|
2
|
Resverlogix Corp.
|
Nov 09, 2017 11:59AM
|
|
Re: Added again....
|
|
Resverlogix Corp.
|
Jun 20, 2017 03:50PM
|
|
Re: Added due to participants
|
3
|
Resverlogix Corp.
|
Jun 20, 2017 12:23PM
|
|
Re: Additional Exempt Distributions
|
2
|
Zenith Epigenetics
|
Oct 13, 2023 03:59PM
|
|
Re: Additional Exempt Distributions
|
|
Zenith Epigenetics
|
Oct 14, 2023 10:48AM
|
|
Re: Additional Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Jul 24, 2023 05:11PM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
6
|
Resverlogix Corp.
|
May 14, 2020 09:33AM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
5
|
Resverlogix Corp.
|
May 14, 2020 10:37AM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
2
|
Resverlogix Corp.
|
May 14, 2020 05:16PM
|
|
Re: After the dust settles in 3 weeks
|
2
|
Resverlogix Corp.
|
Oct 23, 2015 03:42PM
|
|
Re: AGM
|
3
|
Resverlogix Corp.
|
Nov 21, 2020 10:07AM
|
|
Re: AGM
|
|
Resverlogix Corp.
|
Jun 20, 2023 08:27AM
|
|
Re: AGM
|
3
|
Resverlogix Corp.
|
Jun 20, 2023 09:58AM
|
|
Re: AGM
|
1
|
Resverlogix Corp.
|
Jun 20, 2023 11:39AM
|
|
Re: AGM
|
|
Resverlogix Corp.
|
Jun 20, 2023 03:01PM
|
|
Re: Agm
|
3
|
Resverlogix Corp.
|
Dec 14, 2017 02:30PM
|
